SYK Stryker Corporation

XNYS Sideways Alert

Health Care

· How we analyze

About the company

Stryker is a major US medical technology company. It makes hip and knee replacements, surgical robots, surgical instruments, hospital beds and neurosurgery products. Customers are hospitals in many countries. As of Oct 11, 2026

Fact sheet (from the annual report) Medical instruments · Portage, USA

Stryker offers products and services in the areas MedSurg, Neurotechnology and Orthopaedics. MedSurg and Neurotechnology comprises surgical equipment and navigation systems, endoscopy, patient handling and emergency care as well as products for stroke, venous thromboembolism and neurosurgery. Orthopaedics mainly supplies implants for hip, knee, shoulder and ankle replacement as well as for trauma and extremities surgery, plus the Mako robotic system. The products are sold through its own subsidiaries as well as dealers and distributors, mostly directly to physicians, hospitals and other facilities.

Automatically summarized from SEC annual report (10-K, filed Feb 11, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

Price performance at a glance

Last 30 trading days
  • Today −1.5%
  • 7 days −1.0%
  • 30 days +10.7%
  • 1 year −21.5%
Day range (last trading day)
−0.8%Price at 38% of the range+1.4%
52-week range
−11.4%Price at 28% of the range+29.2%
Distance from the all-time high
−25.8%

Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Where is the price relative to the buy zone?

No buy zone

There is currently no buy zone for this symbol under our Elliott rule. One only forms when the price pulls back after a strong rise.

An observation, not investment advice

Rule (4-hour candles) No active buy zone – the last one ended on Oct 16, 2026 · Buy zone no longer valid

Watcher Full history: every change of the buy zone with its date.

Automated analysis (rule-based)

How we analyze

Timeframe 4 hours · As of Oct 27, 2026

Elliott wave analysis Stryker (4-hour candles): Triangle (contracting, symmetrical), Corrective pattern (downward), e complete (3 of 4 guidelines) (smaller wave degree); no buy zone of the rule on this timeframe. Candlestick chart SYK with 122 4-hour candles from Jul 31, 2026, 19:30 to Oct 27, 2026, 14:30. No buy zone of the rule on this timeframe – only the Elliott count: Triangle (contracting, symmetrical), Corrective pattern (downward), e complete (3 of 4 guidelines) (b = 28% of a; c = 93% of b; d = 80% of c; e = 83% of d), invalid on a close below the end of e. smaller wave degree: Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart. Alternative: Combination (W-X-Y), Corrective pattern (downward), Y complete (2 of 3 guidelines). No value axis. Automated analysis (rule-based), not investment advice. SYK · 4-hour candles · Automated analysis (rule-based) No buy zone of the rule – Elliott count only Smaller wave degree: more sensitive turning points – check the count yourself on the chart invalid on a close below the end of e 0 a b c d e complete Sep Oct last candle Oct 27, 2026, 14:30 · not investment advice Without a buy zone of the rule: no value axis
  • 4-hour candles (green = close above open, red = below)
  • Elliott count (thin gold line, waves in circles; dashed circle = still in progress; small = subwaves; red dashed = invalidation level)
  • Dashed throughout with a label: fallback count (smaller wave degree) – provisional, check it yourself on the chart

Elliott count: Triangle (contracting, symmetrical), Corrective pattern (downward), e complete (3 of 4 guidelines) · b = 28% of a; c = 93% of b; d = 80% of c; e = 83% of d

smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.

Position: Position not clear (allowed in wave 4, B or X)

Alternative (not drawn): Combination (W-X-Y), Corrective pattern (downward), Y complete (2 of 3 guidelines)

Note: Inner waves a–d are three-part and not triangles.

Note: Count questionable: Y in progress at 219% (Y of W, limit 161.8%).

Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.

Scenarios

Timeframe 4 hours · As of Oct 27, 2026 · from the Elliott count in the analysis chart

Weighting Main scenario: ahead (3 of 4 guidelines, strong) · Alternative: behind (2 of 3, medium)

Weighting by guidelines met – not a probability.

smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.

Main scenario

ahead strong · 3 of 4 guidelines

As long as the 4-hour close stays above the end of e, this applies: Sideways phase in five waves (Triangle, contracting, symmetrical), e complete – count points to rising prices.

Invalid if the 4-hour close is below the end of e

Alternative

behind medium · 2 of 3 guidelines

If that breaks, the second reading no longer applies either: complex countermove downward (Combination W-X-Y), Y complete – then there is no valid count for now; the next candles will produce a new one.

Invalid if the 4-hour close is below the end of Y

Fundamental analysis

Stryker Corporation · Sector Health Care · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 11, 2026.

In short

  • Light green: Revenue grew over 5 years (+11.8% per year), at least as fast as the sector median.
  • Light green: Net income (total) grew over 5 years (+15.2% per year), at least as fast as the sector median; per share +14.9% per year.
  • Light green: Net margin 12.9%, above the sector median (12.9%).
  • Light green: Debt not higher than usual in the sector.
  • Light green: Profit in each of the last 10 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 11.3B USD · Net income 1.6B USD · Net margin 14.5%
  2. Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 12.4B USD · Net income 1.0B USD · Net margin 8.2%
  3. Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 13.6B USD · Net income 3.6B USD · Net margin 26.1%
  4. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 14.9B USD · Net income 2.1B USD · Net margin 14.0%
  5. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 14.4B USD · Net income 1.6B USD · Net margin 11.1%
  6. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 17.1B USD · Net income 2.0B USD · Net margin 11.7%
  7. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 18.4B USD · Net income 2.4B USD · Net margin 12.8%
  8. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 20.5B USD · Net income 3.2B USD · Net margin 15.4%
  9. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 22.6B USD · Net income 3.0B USD · Net margin 13.2%
  10. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 25.1B USD · Net income 3.2B USD · Net margin 12.9%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 25.1B USD · Net income 3.2B USD · Net margin 12.9%

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+11.8% per year, last 5 years

Sector Health Care: median +7.8% (60 symbols)

What does this mean? Revenue: over 5 years it grew by 11.8% per year on average – at least as fast as the median company in the sector (+7.8%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light green: above sector

+15.2% per year, last 5 years

Sector Health Care: median +7.5% (46 symbols)

per share: +14.9% per year (5 years, split-adjusted)

What does this mean? Total net income: over 5 years it grew by 15.2% per year on average – at least as fast as the median company in the sector (+7.5%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light green: above sector

12.9% last fiscal year

Sector Health Care: median 12.9% (63 symbols)

What does this mean? Of every 100 USD in revenue, 12.92 USD remained as profit – at least as much as the median company in the sector (12.9%). Five years ago the margin was 11.1%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light green: lower than sector

0.59 latest balance sheet

Sector Health Care: median 0.66 (40 symbols)

What does this mean? For every 1 USD of equity there is 0.59 USD of financial debt – no more than the median company in the sector (0.66). More debt amplifies good and bad years alike.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light gray: none found

– Dividend / earnings per share

Sector Health Care: median 28% (31 symbols)

What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light green: profit every year

10 of 10 fiscal years with a profit

What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
25.1B USD
Revenue vs. prior year
+11.2%
Net income (FY)
3.2B USD
Net income vs. prior year
+8.5%
EPS (FY)
8.40 USD
13F funds with a position
1 of 9
Funds vs. prior quarter
−1
Shares held vs. prior quarter
+1,516.3%
Fiscal year to Dec 31, 2025 · 10-K filed Feb 11, 2026 · Balance sheet Jun 30, 2026 (filed Jul 31, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 25.1B3.2B 12.9% 8.40 – –
2024Dec 31, 2024 22.6B3.0B 13.2% 7.76 – –
2023Dec 31, 2023 20.5B3.2B 15.4% 8.25 – –
2022Dec 31, 2022 18.4B2.4B 12.8% 6.17 – –
2021Dec 31, 2021 17.1B2.0B 11.7% 5.21 – –
2020Dec 31, 2020 14.4B1.6B 11.1% 4.20 – –
2019Dec 31, 2019 14.9B2.1B 14.0% 5.48 – –
2018Dec 31, 2018 13.6B3.6B 26.1% 9.34 – –
2017Dec 31, 2017 12.4B1.0B 8.2% 2.68 – –
2016Dec 31, 2016 11.3B1.6B 14.5% 4.35 1.57 36%
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q2/26Jun 30, 2026 6.6B1.3B 19.4% 3.30 0.88 27%
Q1/26Mar 31, 2026 6.0B745.0M 12.4% 1.93 0.88 46%
Q4/25Dec 31, 2025 7.2B849.0M 11.8% 2.20 0.88 40%
Q3/25Sep 30, 2025 6.1B859.0M 14.2% 2.22 0.84 38%
Q2/25Jun 30, 2025 6.0B884.0M 14.7% 2.29 0.84 37%
Q1/25Mar 31, 2025 5.9B654.0M 11.1% 1.69 0.84 50%
Q4/24Dec 31, 2024 6.4B546.0M 8.5% 1.41 0.84 60%
Q3/24Sep 30, 2024 5.5B834.0M 15.2% 2.16 0.80 37%
Q2/24Jun 30, 2024 5.4B825.0M 15.2% 2.14 0.80 37%
Q1/24Mar 31, 2024 5.2B788.0M 15.0% 2.05 0.80 39%
Q4/23Dec 31, 2023 5.8B1.1B 19.7% 2.98 0.80 27%
Q3/23Sep 30, 2023 4.9B692.0M 14.1% 1.80 0.75 42%

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $118.2M3 people −$118.2M
6 months $00 people $218.9M5 people −$218.9M
12 months $00 people $586.1M8 people −$586.1M

Latest transactions

  • Aug 21, 2026 Crotty Dylan Bram Officer Open-market sale 441 shares · $144.9K · SEC
  • Aug 19, 2026 Stryker Ronda E Director Open-market sale 805 shares · $276.5K · SEC
  • Aug 19, 2026 Stryker Ronda E Director Open-market sale 3,852 shares · $1.3M · SEC
  • Aug 19, 2026 Stryker Ronda E Director Open-market sale 3,274 shares · $1.1M · SEC
  • Aug 19, 2026 Stryker Ronda E Director Open-market sale 16,612 shares · $5.7M · SEC
  • Aug 19, 2026 Stryker Ronda E Director Open-market sale 10,812 shares · $3.7M · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score -15

Price vs. EMA 50+15
Price vs. EMA 200-15
EMA 50 vs. EMA 200-20
ADX (trend strength)+0
Highs and lows+20
Relative strength-15

Volatility and trend strength

ADX 14 (trend strength)19.3
Rel. strength 60 d−12.5%

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

No recent news found. News are loaded automatically three times a day for trending stocks, symbols with a buy zone and favorites.

Posts

No posts on SYK yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: SYK

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

↑ ↓ select · Enter open · Esc close